» Articles » PMID: 18059174

Biology of Breast Cancer Bone Metastasis

Overview
Specialties Oncology
Pharmacology
Date 2007 Dec 7
PMID 18059174
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Breast carcinoma ranks among the most prevalent malignancies in women. Breast carcinoma frequently metastasizes to bone and approximately 70% of patients with breast cancer have bone metastases, which generally are osteolytic lesions. They cause major morbidity and mortality in patients; and the available treatment options are limited. Bone-specific homing and colonization of cancer cells are important and interesting features of metastasis. There are complex and multiple steps in the process of bone metastasis; and the elaborate interaction between breast carcinoma and bone involves various cytokines, growth factors and cellular signals, which results in a vicious cycle and promotes tumor cell accumulation and osteolysis. Recent advances in molecular biology have resulted in major breakthroughs in our understanding of the pathogenesis of bone metastasis in breast cancer, which is critical in preventing metastasis, designing novel and targeted treatments and prolonging survival in this devastating condition.

Citing Articles

IL-1β in Neoplastic Disease and the Role of Its Tumor-Derived Form in the Progression and Treatment of Metastatic Prostate Cancer.

Oyende Y, Taus L, Fatatis A Cancers (Basel). 2025; 17(2).

PMID: 39858071 PMC: 11763358. DOI: 10.3390/cancers17020290.


Extracellular Regucalcin: A Potent Suppressor in the Cancer Cell Microenvironment.

Yamaguchi M Cancers (Basel). 2025; 17(2).

PMID: 39858022 PMC: 11763602. DOI: 10.3390/cancers17020240.


Correctly identifying the cells of origin is essential for tailoring treatment and understanding the emergence of cancer stem cells and late metastases.

Waldum H, Slupphaug G Front Oncol. 2024; 14:1369907.

PMID: 38660133 PMC: 11040596. DOI: 10.3389/fonc.2024.1369907.


Regucalcin Is a Potential Regulator in Human Cancer: Aiming to Expand into Cancer Therapy.

Yamaguchi M Cancers (Basel). 2023; 15(22).

PMID: 38001749 PMC: 10670417. DOI: 10.3390/cancers15225489.


Macromorphometric Analysis of Metastatic Lesions in Bones due to Breast Cancer: Contribution to Human Identification.

Pereira E, de Carvalho M, Nascimento E, Queiroz R, de Almeida A, Antunes A Asian Pac J Cancer Prev. 2023; 24(9):3087-3097.

PMID: 37774060 PMC: 10762763. DOI: 10.31557/APJCP.2023.24.9.3087.